- Home
- QNCX vs GRWG Comparison
QNCX vs GRWG Comparison
Compare QNCX & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- GRWG
- Stock Information
- Founded
- QNCX 2012
- GRWG 2008
- Country
- QNCX United States
- GRWG United States
- Employees
- QNCX N/A
- GRWG N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- GRWG RETAIL: Building Materials
- Sector
- QNCX Health Care
- GRWG Consumer Discretionary
- Exchange
- QNCX Nasdaq
- GRWG Nasdaq
- Market Cap
- QNCX 47.7M
- GRWG 51.8M
- IPO Year
- QNCX 2019
- GRWG N/A
- Fundamental
- Price
- QNCX $1.64
- GRWG $1.01
- Analyst Decision
- QNCX Strong Buy
- GRWG Buy
- Analyst Count
- QNCX 5
- GRWG 4
- Target Price
- QNCX $8.00
- GRWG $2.38
- AVG Volume (30 Days)
- QNCX 353.3K
- GRWG 948.1K
- Earning Date
- QNCX 08-12-2025
- GRWG 08-07-2025
- Dividend Yield
- QNCX N/A
- GRWG N/A
- EPS Growth
- QNCX N/A
- GRWG N/A
- EPS
- QNCX N/A
- GRWG N/A
- Revenue
- QNCX N/A
- GRWG $176,681,000.00
- Revenue This Year
- QNCX N/A
- GRWG N/A
- Revenue Next Year
- QNCX N/A
- GRWG N/A
- P/E Ratio
- QNCX N/A
- GRWG N/A
- Revenue Growth
- QNCX N/A
- GRWG N/A
- 52 Week Low
- QNCX $0.51
- GRWG $0.82
- 52 Week High
- QNCX $2.45
- GRWG $2.70
- Technical
- Relative Strength Index (RSI)
- QNCX 64.95
- GRWG 44.82
- Support Level
- QNCX $1.48
- GRWG $0.87
- Resistance Level
- QNCX $1.68
- GRWG $1.05
- Average True Range (ATR)
- QNCX 0.14
- GRWG 0.07
- MACD
- QNCX 0.02
- GRWG -0.01
- Stochastic Oscillator
- QNCX 85.71
- GRWG 41.18
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.